Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoglobin solutions.

Jacques Creteur1, Jean-Louis Vincent

  • 1Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Belgium.

Critical Care Medicine
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of therapeutic hypothermia on brain function in a refractory cardiac arrest model treated with extracorporeal cardiopulmonary resuscitation.

Intensive care medicine experimental·2025
Same author

An increase in skin blood flow after red blood cell transfusion is associated with an improvement in organ function in critically ill patients.

Journal of critical care·2025
Same author

Prediction of biological evolution following blood product transfusion during liver transplantation: the contribution of machine learning to decision-making.

BMJ health & care informatics·2025
Same author

Early administration of vitamin C in patients with sepsis or septic shock in emergency departments: a multicenter, double-blind, randomized controlled trial: the C-EASIE trial.

Critical care (London, England)·2025
Same author

Alterations in the renin-angiotensin system during septic shock.

Annals of intensive care·2025
Same author

Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial.

Annals of intensive care·2024

Cell-free hemoglobin solutions show promise as resuscitative agents, improving circulation and metabolism. However, potential adverse effects like vasoconstriction and oxidative damage require careful evaluation before widespread use.

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Resuscitation Medicine

Background:

  • Cell-free hemoglobin solutions are being explored as alternatives to red blood cell transfusions.
  • These solutions aim to leverage hemoglobin's oxygen-carrying capacity without the need for intact red blood cells.

Purpose of the Study:

  • To review current scientific knowledge on cell-free hemoglobin solutions.
  • To assess their efficacy, safety, and potential applications in medical settings.

Main Methods:

  • A comprehensive literature search of MEDLINE (1990-2003) and review articles was conducted.
  • Included clinical and experimental studies investigating cell-free hemoglobin solutions.

Main Results:

  • Hemoglobin solutions demonstrated potential as resuscitative agents, improving microcirculation and metabolic parameters.

Related Experiment Videos

  • Key challenges identified include systemic vasoconstriction and oxidative damage.
  • Recent trials have tempered initial enthusiasm, highlighting the need for further investigation.

    • Conclusions:

    • First-generation cell-free hemoglobin solutions have known effects, with ongoing research into newer variants.
    • Future developments focus on molecular modifications to minimize adverse events, such as nitric oxide binding.
    • Thorough evaluation of safety is crucial before clinical adoption.